CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3...

μοιράστηκε ένα σύνδεσμο

2025-03-25 10:48:37 - Μετάφραση -

Bladder Cancer Detection: The Role of Cystoscopy

Cystoscopy is a key procedure for diagnosing bladder cancer, allowing doctors to examine the bladder lining for abnormalities. Early detection is crucial for effective treatment! If you’re experiencing symptoms like blood in urine or frequent urination, consult a specialist. Stay informed, stay proactive!

https://cgoncology.com/cg-oncology-announces-first-patient-dosed-in-pivot-006-phase-3-clinical-trial-of-cretostimogene-in-intermediate-risk-non-muscle-invasive-bladder-cancer/

#BladderCancer #Cystoscopy #HealthAwareness

Bladder Cancer Detection: The Role of Cystoscopy Cystoscopy is a key procedure for diagnosing bladder cancer, allowing doctors to examine the bladder lining for abnormalities. Early detection is crucial for effective treatment! If you’re experiencing symptoms like blood in urine or frequent urination, consult a specialist. Stay informed, stay proactive! https://cgoncology.com/cg-oncology-announces-first-patient-dosed-in-pivot-006-phase-3-clinical-trial-of-cretostimogene-in-intermediate-risk-non-muscle-invasive-bladder-cancer/ #BladderCancer #Cystoscopy #HealthAwareness

CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancer - CG Oncology |

– PIVOT-006 Phase 3 open-label trial of adjuvant cretostimogene is CG Oncology’s earliest disease stage clinical trial for patients with Non-Muscle Invasive Bladder Cancer (NMIBC) – – Primary endpoint of PIVOT-006 Phase 3 clinical trial is overall recurrence-free survival (RFS), with secondary endpoints including RFS at 12 and 24 months and progression-free survival (PFS) – […]

0 Σχόλια 0 Μοιράστηκε 502 Views